Clinical Updates in Migraine: Dawn of a New Day

[ev_gap height=”20″]

CME Information

Program Overview

Migraine is the most common neurologic disease seen in the primary care setting, affecting 13% of the US population. There are not enough neurologists or headache specialists to see the 38 million individuals with migraine. For years there have been no advances in therapies to treat and prevent this financially and socially crippling illness. Providers and patients have had to resort to settling for limited improvement in symptoms and look to non-targeted medications with a potential for serious side effects for preventative options. With the new CGRP targeted therapies brings new hope for significant relief for migraine sufferers. The safety, ease of use, and tolerability of these medications herald an opportunity for primary care to make a huge impact on the quality of life for their migraine patients. Join us to review the pathophysiology of migraine, what we learned in training and what’s new today. Review traditional treatment approaches and how to successfully implement the new CGRP targeted medications, both currently available and those pending FDA approval, in treating and preventing migraines in your clinical practice.

The following activities were developed from the live migraine conference that took place in Irvine, CA on November 2, 2019.

[ev_gap height=”20″]

Learning Objectives

After participating in these activities, participants should be better able to:

Part 1: Epidemiology, Diagnosis, Pathophysiology
Identify the migraine types and the neuroinflammatory peptides that play a role in migraine pathogenesis, and how they affect migraine pathways

Part 2: Treatment
Describe current and emerging treatment options for migraine
Recognize how CGRP targeted therapies can modulate treatment

Part 3: Special Populations and Menstrual Migraine (includes Q&A session)
Incorporate optimal acute and preventive treatment of migraine in special populations

Release/Expiration Dates

This internet, enduring activity (audio/video, slides) will be available for one year, beginning December 30, 2019 through December 30, 2020.

This activity was reviewed and re-released on December 31, 2020 and will be available for credit until June 30, 2021.

[ev_gap height=”20″]
[ev_gap height=”20″]

Faculty

[ev_gap height=”20″]

Linda Davis, MD
Founder and Medical Director
Kolvita Family Medical Group, Inc.
Mission Viejo, CA

Susan Hutchinson, MD
Director and Founder, Orange County Migraine & Headache Center
Volunteer Faculty, Department of Family Medicine at UC-Irvine Medical Center
Irvine, CA

[ev_gap height=”20″]
[ev_gap height=”20″]

Target Audience

This activity is targeted to any primary care clinician who treats patients with migraine.

Acknowledgement of Commercial Support

This activity has been supported through an independent educational grant from Teva Pharmaceuticals.

Accreditation – AMA PRA Category 1 Credit

Primary Care Network is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Primary Care Network designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Part 1: Epidemiology, Diagnosis, Pathophysiology
0.75 AMA PRA Category 1 Credit

Part 2: Treatment
1.25 AMA PRA Category 1 Credits

Part 3: Special Populations and Menstrual Migraine (includes Q&A session)
1.25 AMA PRA Category 1 Credits

NURSE PRACTITIONERS
The American Academy of Nurse Practitioners Certification Program (AANPCP) and American Nurses Credentialing Center (ANCC) accept AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

All other healthcare professionals will be issued a certificate of participation.

American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Part 1 offers 0.75 MOC points, Part 2 offers 1.25 points and Part 3 offers 1.25 points. Participants will earn MOC points equivalent to the amount of CME credits claimed for each part of the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive CME credit and/or MOC points, you MUST complete the activity and the evaluation form. For ABIM MOC points, your information will be shared with the ABIM through PCN’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

 

 

 

Activity provided by Primary Care Network.

This activity has expired and is no longer available for CME; however, we hope you still enjoy the education.

[ev_gap height=”20″]

Published December 30, 2019